SEC Form 4 · accession 0001156375-16-000267

CME GROUP INC. · CME

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President

Period of report

Dec 28, 2016

Accepted (ET)

Dec 29, 2016 · 5:53 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156375

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock Class A	Dec 28, 2016	M	12,280	$54.37	A	65,960	D
Common Stock Class A^F1,F2	Dec 28, 2016	S	12,280	$116.3919	D	53,680	D
Common Stock Class A	Dec 28, 2016	M	2,606	$54.30	A	56,286	D
Common Stock Class A^F1,F2	Dec 28, 2016	S	2,606	$116.3919	D	53,680	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F3	$54.30	Dec 28, 2016	M	2,606	D	Sep 15, 2014	Sep 15, 2020	Common Stock Class A	2,606	0	D
Non-Qualified Stock Option (right to buy)^F4	$54.37	Dec 28, 2016	M	12,280	D	Sep 15, 2015	Sep 15, 2021	Common Stock Class A	12,280	0	D

F1This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.
F2On December 28, 2016, Mr. Durkin sold an aggregate of 14,886 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $115.87 to $115.97; $116.00 to $116.87; and $117.09 to $117.18. The Company maintains a record of the transactions and copies will be provided upon request.
F3On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option.
F4On September 15, 2015, these options vested with respect to 100% of the granted number of shares covered by the option.